ArticleEndocrine-related cancer2023

Cabozantinib in neuroendocrine tumors: tackling drug activity and resistance mechanisms.

Chiara Alessandra Cella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.